CAS: 22298-29-9; Betamethasone Benzoate

该化合物是一种合成的花生类固醇,具有抗炎和免疫抑制特性,它来自乙型甲胺酮,一种强大的甘油素,其特点是17点位置有苯甲酸酯酯,其特征是17点位置存在一种苯甲酸酯酯酯.这种改变增强了其脂质性,允许在热剂中改善皮肤渗透度和长期作用.该化合物通常是白到白的晶体粉,在乙醇和丙酮等有机溶剂中溶解,但在水中溶解性有限.Betamethasone 17-Benzoate通常用于皮肤病的配方,治疗各种皮肤病,包括乙酰胺,丙烯和皮肤炎,因为其能够减少炎情,抑制免疫反应.该化合物的药效通过基因表达方式调节,导致减少类食性细胞素的生产,但水中溶液溶性作用有限.除了其他的表面吸收作用外,应仔细监测其使用,包括系统吸收作用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9051302-B2
    优先权日:2008-01-15
    标 题 :Synthesis of resorcylic acid lactones useful as therapeutic agents
    发明人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN
    权利人:WINSSINGER NICOLAS; BARLUENGA SOFIA; KARPLUS MARTIN; UNIV STRASBOURG
    摘要:Disclosed are macrocyclic compounds of formulae I, I′, II, II′, III, III′, IV, and V, which are analogs of the pochonin resorcylic acid lactones, pharmaceutical compositions comprising the compounds, and methods and uses comprising the compounds for the treatment of diseases mediated by kinases and Heat Shock Protein 90 HSP90.

    专利号:US-8926955-B2
    优先权日:2008-12-22
    标题 :Synthesis of polymer conjugates of indolocarbazole compounds
    发明人:BAGNOD RAFFAELLA; BECCARIA LUCA; BERTARIONE RAVA ROSSA LUISA; CRISCUOLO DOMENICO; LORENZETTO CHIARA; MAINERO VALENTINA; MARCONI ALESSANDRA; PINCELLI CARLO; TRAVERSA SILVIO
    权利人:BAGNOD RAFFAELLA; BECCARIA LUCA; BERTARIONE RAVA ROSSA LUISA; CRISCUOLO DOMENICO; LORENZETTO CHIARA; MAINERO VALENTINA; MARCONI ALESSANDRA; PINCELLI CARLO; TRAVERSA SILVIO; CREABILIS S A
    摘要:The present invention relates to a process for the preparation of polymer conjugates of indolocarbaxole compounds, in particular of polymer conjugates of K-252a and derivatives thereof, by a synthetic route which results in a highly pure product, with a high product yield. In a further aspect the present invention relates to novel polymer conjugates of K-252a and derivatives thereof, wherein the chemical group linking the polymer unity to the K-252a or to the K-252a derivative compound is characterized by a 5-member oxazolidindionic cyclic structure. These novel polymer conjugates are obtained through the novel synthetic route with high purity and high yields.

    专利号:WO-9709067-A1
    优先权日:1995-09-05
    标 题 :Combination of 5-lipoxygenase and leukotriene synthesis inhibitors with glucocorticosteroids
    发明人:BURCHARDT ELMAR-REINHOLD; MUELLER-PEDDINGHAUS REINER
    权利人:BAYER AG; BURCHARDT ELMAR REINHOLD; MUELLER PEDDINGHAUS REINER
    摘要:The combination is disclosed of 5-lipoxygenase inhibitors as direct action lipoxygenase inhibitors (LOI) or of leukotriene synthesis inhibitors (LSI) with glucocorticosteroids (GCS). This combination is suitable for treating and preventing various acute and chronic inflammatory processes, in particular of the respiratory tract, and may therefore be used as a medicament, in particular for treating asthma.

    专利号:US-2021244638-A1
    优先权日:2018-06-05
    标 题:Inhibitors of glycosphingolipid synthesis and methods of use
    发明人:CHATTERJEE SUBROTO B
    权利人:SUBROTO B CHATTERJEE
    摘要:Compositions in the prevention and treatment of skin diseases or associated disorders, inflammation or inflammatory diseases or disorders, include at least one inhibitor of glycosphingolipid synthesis.

    专利号:CA-2747838-C
    优先权日:2008-12-22
    标 题 :Synthesis of polymer conjugates of indolocarbazole compounds

    专利号:WO-2024233563-A1
    优先权日:2023-05-09
    标 题:6,6-fused bicyclic amides and compositions for use as 15-prostaglandin dehydrogenase modulators
    发明人:GREENMAN KEVIN LLOYD; WANG HUI-LING; WEIRES NICHOLAS ANTHONY; ALLEN JOHN G; AMEGADZIE ALBERT K; BOURBEAU MATTHEW P; LI KEXUE
    权利人:AMGEN INC
    摘要:The present disclosure provides novel 15-hydroxy-prostaglandin dehydrogenase inhibitors, pharmaceutical compositions comprising such compounds, and methods of using such compounds and compositions in treating 15-hydroxy-prostaglandin dehydrogenase-mediated disease. Also provided are methods of making such compounds and intermediates thereof. The compounds have a structure of Formula (I): or a pharmaceutically acceptable salt thereof; wherein is Formula (i) or Formula (ii) Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知